ARTERIAL DISEASE MULTIPLE INTERVENTION TRIAL (ADMIT)

众所周知，患有外周动脉疾病的人处于 增加心血管疾病发病率和死亡率的风险。为了 促进设计一项试验，以评估干预的效果 危险因素对此类患者发病率和死亡率的影响 研究(ADAM)旨在评估招募、治疗 并保留志愿者，以期进行大规模的多中心研究 着力降低风险因素。

It is known that individuals with peripheral arterial disease are at increased risk for cardiovascular morbidity and mortality. In order to facilitate design of a trial to evaluate the effects of intervention on risk factors on morbidity and mortality in such patients a feasibility study (ADMIT) has been designed to evaluate the ability to recruit, treat and retain volunteers in anticipation of a large scale multi-center study focusing on risk factor reduction.